GLTO
Price
$4.26
Change
+$0.04 (+0.95%)
Updated
Sep 24, 12:01 PM (EDT)
Capitalization
5.59M
VIVS
Price
$3.75
Change
-$0.06 (-1.57%)
Updated
Sep 24, 11:54 AM (EDT)
Capitalization
9.91M
Interact to see
Advertisement

GLTO vs VIVS

Header iconGLTO vs VIVS Comparison
Open Charts GLTO vs VIVSBanner chart's image
Galecto
Price$4.26
Change+$0.04 (+0.95%)
Volume$9.77K
Capitalization5.59M
VivoSim Lab
Price$3.75
Change-$0.06 (-1.57%)
Volume$100
Capitalization9.91M
GLTO vs VIVS Comparison Chart in %
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. VIVS commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Buy and VIVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GLTO: $4.22 vs. VIVS: $3.81)
Brand notoriety: GLTO and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 4168% vs. VIVS: 19%
Market capitalization -- GLTO: $5.59M vs. VIVS: $9.91M
GLTO [@Biotechnology] is valued at $5.59M. VIVS’s [@Biotechnology] market capitalization is $9.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 1 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 1 green, 4 red.
According to our system of comparison, VIVS is a better buy in the long-term than GLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 5 TA indicator(s) are bullish while VIVS’s TA Score has 5 bullish TA indicator(s).

  • GLTO’s TA Score: 5 bullish, 4 bearish.
  • VIVS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GLTO and VIVS are a good buy in the short-term.

Price Growth

GLTO (@Biotechnology) experienced а +53.45% price change this week, while VIVS (@Biotechnology) price change was -0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.09%, and the average quarterly price growth was +53.86%.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIVS($9.91M) has a higher market cap than GLTO($5.59M). VIVS YTD gains are higher at: 728.441 vs. GLTO (-9.247). VIVS has higher annual earnings (EBITDA): -1.72M vs. GLTO (-16.94M). GLTO has more cash in the bank: 10.2M vs. VIVS (9.06M). GLTO has less debt than VIVS: GLTO (75K) vs VIVS (822K). VIVS has higher revenues than GLTO: VIVS (142K) vs GLTO (0).
GLTOVIVSGLTO / VIVS
Capitalization5.59M9.91M56%
EBITDA-16.94M-1.72M987%
Gain YTD-9.247728.441-1%
P/E RatioN/AN/A-
Revenue0142K-
Total Cash10.2M9.06M113%
Total Debt75K822K9%
FUNDAMENTALS RATINGS
VIVS: Fundamental Ratings
VIVS
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOVIVS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELC52.500.01
+0.02%
Celcuity
ZKH2.97N/A
N/A
ZKH Group Limited
CELH51.01-0.33
-0.64%
Celsius Holdings
RDHL1.62-0.05
-2.99%
Redhill Biopharma Ltd
HYFT1.91-0.10
-4.98%
MindWalk Holdings Corp.

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+40.67%
TCRT - GLTO
56%
Loosely correlated
+12.10%
VIVS - GLTO
38%
Loosely correlated
+2.42%
DNLI - GLTO
35%
Loosely correlated
-2.03%
SYRE - GLTO
35%
Loosely correlated
+4.77%
ACRV - GLTO
34%
Loosely correlated
-4.82%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+2.42%
LVTX - VIVS
41%
Loosely correlated
+1.28%
GLTO - VIVS
38%
Loosely correlated
+40.67%
RENB - VIVS
26%
Poorly correlated
+1.05%
KRRO - VIVS
26%
Poorly correlated
+3.57%
PDSB - VIVS
26%
Poorly correlated
-2.78%
More